PlainPill

Baclofen

The short answer. More people than not who report on Baclofen say it helped (61% of 28). It is most often used for anxiety: 89% of 18 reports say that improved. It is well studied — 168 meta-analyses on PubMed.

What users report
61%helped28 reports · medium confidence
17 helped5 mixed6 didn't help

From 68 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
168
meta-analyses
214
RCTs
8,272
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Baclofen does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 168 meta-analyses on PubMed ↗ · 214 randomized trials ↗

Curr Neurol Neurosci Rep · 2020 · Meta-analysis / systematic review
State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy

Conclusion: Effective medical and surgical interventions include anti-convulsants, bisphosphonates, botulinum toxin, botulinum toxin plus occupational therapy, botulinum toxin plus casting, diazepam, dentistry, hip surveillance, intrathecal baclofen, scoliosis correction, selective dorsal rhizotomy, and umbilical cord blood cell therapy. We have provided guidance about what works and what does not to inform decision-making, and highlighted areas for more research.

PubMed 32086598 ↗
J Addict Med · 2022 · Meta-analysis / systematic review
Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis

Conclusion: The current meta-analyses provide evidence that several medications for AUDs are effective and safe and encourage the expanded use of these medications in the clinical setting. Our review found that acamprosate (2-3 g/d), disulfiram (250-500 mg/d), baclofen (30 mg/d), and oral naltrexone (50 mg/d) had the best evidence for improving abstinence and heavy drinking for patients with AUD.

PubMed 35653782 ↗
Dev Med Child Neurol · 2021 · Meta-analysis / systematic review
Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta-analysis

Conclusion: Evidence evaluating the use of pharmacological and neurosurgical management options for individuals with CP and dystonia is limited to between low and very low certainty. What this paper adds Meta-analysis suggests that intrathecal baclofen (ITB) and deep brain stimulation (DBS) may improve dystonia and pain. Meta-analysis suggests that DBS may improve motor function. Clonidine, botulinum neurotoxin, ITB, and DBS may improve achievement of individualized goals. ITB and DBS may improve quality of life. No direct evidence is available for oral baclofen, benzodiazepines, gabapentin, or medical ca

PubMed 33772789 ↗
BMJ Clin Evid · 2014 · Meta-analysis / systematic review
Dystonia

Conclusion: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: acupuncture, amantadine, baclofen, benzatropine, biofeedback, botulinum toxins, bromocriptine, carbamazepine, carbidopa/levodopa, clonazepam, clozapine, deep brain stimulation of thalamus and globus pallidus, diazepam, gabapentin, haloperidol, lorazepam, myectomy (for focal dystonia), occupational therapy, ondansetron, physiotherapy, pregabalin, procyclidine, selective peripheral denervation (for focal dystonia), speech therapy, tizanidine, trazodone hydrochloride, and tri

PubMed 25347760 ↗
Registered clinical trials

147 human trials on ClinicalTrials.gov test Baclofen — 88 completed, 9 recruiting now. See all on ClinicalTrials.gov ↗

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

FDA drug label

Boxed warning (the FDA's strongest label warning): “DO NOT DISCONTINUE ABRUPTLY Abrupt discontinuation of intrathecal baclofen, regardless of the cause, has resulted in sequelae that include high fever, altered mental status, exaggerated rebound spasticity, and muscle rigidity, that in rare cases has advanced to rhabdomyolysis, multiple…”

Full label on DailyMed (NIH) ↗

FDA recalls

22 recalls of products named for Baclofen. Most recent:

  • 2025-12-24 · Class II: Presence of Foreign Tablets/Capsules record ↗
  • 2020-01-22 · Class II: Lack of sterility assurance. record ↗
  • 2019-12-18 · Class II: Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi. record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Reports to the FDA about the drug (FAERS)

85,600 adverse-event reports mention Baclofen. Most often reported:

  • Fatigue · 6,276
  • Pain · 5,749
  • Drug ineffective · 5,604
  • Fall · 5,500
  • Nausea · 4,711
  • Headache · 4,461

Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗

Liver safety (LiverTox, NIH)

LiverTox rates Baclofen D — a possible rare cause of liver injury (1–3 published cases). LiverTox entry ↗

US government research funding (NIH)

NIH has funded 28 research projects with Baclofen in the title, $11,163,664 in total (1985–2026). NIH RePORTER ↗

Plain-language guides from the US government: MedlinePlus: Baclofen ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

withdrawal ×2dizziness ×1hallucinations ×1insomnia ×1agitation ×1depression ×1possible impaired ×1anxiety ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“Baclofen(10/10): Not really a nootropic, but it felt identical to phenibut. Whats even better, I was able to take it regularly and keep the anxiety-reducing benefits...”
HelpedRead the discussion ↗
“It works well. Currently taking 20mg/day, but will have to increase because I am not quite satisfied with the results. Having said that, I feel a little dizzy even on 20mg.”
MixedRead the discussion ↗
“The #1 tool in my arsenal. It helped me get out of my own thoughts and just live. I simply feel more alive, upbeat, enthusiastic, better mood, more outgoing/charming, more energy.”
HelpedRead the discussion ↗
“Baclofen. I take 50 mg daily. Works great, almost no tolerance build up.”
HelpedRead the discussion ↗
Read more Baclofen reviews →
Top discussions (5)

Baclofen compared

Other options for anxiety

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate